Literature DB >> 29751167

Efficacy and Follow-up of Segmental or Subtotal Colectomy in Patients With Colitis-Associated Neoplasia.

Noa Krugliak Cleveland1, Jacob E Ollech1, Ruben J Colman1, Dylan Rodriquez1, Ayal Hirsch1, Russell D Cohen1, Stephen B Hanauer2, John Hart1, Roger Hurst1, David T Rubin3.   

Abstract

The historical approach to neoplasia in the setting of chronic colitis was to perform a total proctocolectomy. Recent consensus and society guidelines1-3 suggest that when dysplastic lesions can be removed endoscopically, continued surveillance is appropriate. This is based on improvements in optical technologies and the low risk of metachronous colorectal carcinoma in these patients.4-6 We hypothesized that if a lesion was completely removed surgically and followed up endoscopically, metachronous colorectal carcinoma would be a rare occurrence. Thus, segmental resection may be offered as a definitive surgery in patients with chronic colitis and localized colorectal neoplasia in whom endoscopic resection is not feasible. Retention of the distal colon/rectum is expected to result in an overall improved quality of life compared with permanent ileostomy or an ileoanal J-pouch. Here, we report our experience and follow-up evaluation of segmental resections for preoperative neoplasia in patients with Crohn's disease (CD) or ulcerative colitis (UC).
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29751167      PMCID: PMC7034413          DOI: 10.1016/j.cgh.2018.04.061

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  6 in total

1.  Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia.

Authors:  Noa Krugliak Cleveland; Ruben J Colman; Dylan Rodriquez; Ayal Hirsch; Russell D Cohen; Stephen B Hanauer; John Hart; David T Rubin
Journal:  Inflamm Bowel Dis       Date:  2016-03       Impact factor: 5.325

2.  SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease.

Authors:  Loren Laine; Tonya Kaltenbach; Alan Barkun; Kenneth R McQuaid; Venkataraman Subramanian; Roy Soetikno
Journal:  Gastrointest Endosc       Date:  2015-03       Impact factor: 9.427

3.  SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease.

Authors:  Loren Laine; Tonya Kaltenbach; Alan Barkun; Kenneth R McQuaid; Venkataraman Subramanian; Roy Soetikno
Journal:  Gastroenterology       Date:  2015-03       Impact factor: 22.682

Review 4.  Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis.

Authors:  Mathurin Fumery; Parambir S Dulai; Samir Gupta; Larry J Prokop; Sonia Ramamoorthy; William J Sandborn; Siddharth Singh
Journal:  Clin Gastroenterol Hepatol       Date:  2016-12-01       Impact factor: 11.382

Review 5.  Cancer risk after resection of polypoid dysplasia in patients with longstanding ulcerative colitis: a meta-analysis.

Authors:  Linda K Wanders; Evelien Dekker; Bo Pullens; Paul Bassett; Simon P L Travis; James E East
Journal:  Clin Gastroenterol Hepatol       Date:  2013-08-03       Impact factor: 11.382

6.  Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management.

Authors:  Marcus Harbord; Rami Eliakim; Dominik Bettenworth; Konstantinos Karmiris; Konstantinos Katsanos; Uri Kopylov; Torsten Kucharzik; Tamás Molnár; Tim Raine; Shaji Sebastian; Helena Tavares de Sousa; Axel Dignass; Franck Carbonnel
Journal:  J Crohns Colitis       Date:  2017-07-01       Impact factor: 10.020

  6 in total
  5 in total

Review 1.  Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis.

Authors:  G Pellino; D S Keller; G M Sampietro; M Carvello; V Celentano; C Coco; F Colombo; A Geccherle; G Luglio; M Rottoli; M Scarpa; G Sciaudone; G Sica; L Sofo; R Zinicola; S Leone; S Danese; A Spinelli; G Delaini; F Selvaggi
Journal:  Tech Coloproctol       Date:  2020-03-02       Impact factor: 3.781

2.  Extent of Surgical Resection in Inflammatory Bowel Disease Associated Colorectal Cancer: a Population-Based Study.

Authors:  Jessica Bogach; Gregory Pond; Cagla Eskicioglu; Marko Simunovic; Hsien Seow
Journal:  J Gastrointest Surg       Date:  2021-02-08       Impact factor: 3.452

Review 3.  Endoscopic colorectal cancer surveillance in inflammatory bowel disease: Considerations that we must not forget.

Authors:  Paulina Núñez F; Rodrigo Quera; David T Rubin
Journal:  World J Gastrointest Endosc       Date:  2022-02-16

4.  Yield of Random Biopsies During Colonoscopies in Inflammatory Bowel Disease Patients Undergoing Dysplasia Surveillance.

Authors:  Anne B Hu; Kristin E Burke; Bharati Kochar; Ashwin N Ananthakrishnan
Journal:  Inflamm Bowel Dis       Date:  2021-05-17       Impact factor: 5.325

Review 5.  Evolving role of endoscopy in inflammatory bowel disease: Going beyond diagnosis.

Authors:  Paulina Núñez F; Noa Krugliak Cleveland; Rodrigo Quera; David T Rubin
Journal:  World J Gastroenterol       Date:  2021-05-28       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.